• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

Recent Advances in the Study of 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid (CAS: 1379324-43-2)

5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid (CAS: 1379324-43-2) is a pyrimidine derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have highlighted its potential as a key intermediate in the synthesis of novel therapeutic agents, particularly in the development of kinase inhibitors and antiviral compounds. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, synthetic applications, and biological activities.

One of the most notable advancements in the study of 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid is its role in the synthesis of kinase inhibitors. Kinases are critical targets in the treatment of various cancers and inflammatory diseases. Recent research has demonstrated that this compound serves as a versatile building block for the development of selective kinase inhibitors, owing to its unique sulfonyl and carboxylic acid functional groups. These groups facilitate interactions with key amino acid residues in the kinase active site, enhancing inhibitor potency and selectivity.

In addition to its applications in kinase inhibitor development, 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid has also been investigated for its potential antiviral properties. A 2023 study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited promising activity against RNA viruses, including SARS-CoV-2. The study utilized molecular docking and in vitro assays to demonstrate that these derivatives interfere with viral replication by targeting essential viral enzymes. These findings suggest that further optimization of this scaffold could lead to the development of broad-spectrum antiviral agents.

The synthetic accessibility of 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid has also been a focus of recent research. A team of chemists recently developed a scalable and efficient synthetic route for this compound, as described in a 2022 publication in Organic Process Research & Development. The new method employs a one-pot reaction sequence, significantly reducing the number of purification steps and improving overall yield. This advancement is expected to facilitate the large-scale production of the compound for further pharmacological studies.

Despite these promising developments, challenges remain in the optimization of 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid derivatives for clinical use. Issues such as metabolic stability, bioavailability, and off-target effects need to be addressed through systematic structure-activity relationship (SAR) studies. Recent computational modeling efforts have provided valuable insights into the structural modifications required to improve these properties, as highlighted in a 2023 review article in Drug Discovery Today.

In conclusion, 5-Amino-2-(methylsulfonyl)pyrimidine-4-carboxylic acid (CAS: 1379324-43-2) represents a promising scaffold for the development of novel therapeutic agents. Its applications in kinase inhibitor and antiviral drug discovery, coupled with recent advances in synthetic methodologies, underscore its potential as a valuable tool in medicinal chemistry. Future research should focus on optimizing its derivatives for improved pharmacokinetic properties and evaluating their efficacy in preclinical models.

• 100130-05-0(5-amino-2-(methylsulfanyl)pyrimidine-4-carboxylic acid)
• 1780608-62-9(Methyl 5-amino-2-(methylsulfonyl)pyrimidine-4-carboxylate)
• 1150644-53-3(6-Ethyl-2-(methylsulfonyl)pyrimidine-4-carboxylic acid)
• 1370411-46-3(2-Methanesulfonylpyrimidine-4-carboxylic acid)
• 99951-96-9(5-Hydrazinyl-2-(methylsulfanyl)pyrimidine-4-carboxylic acid)
• 1823235-40-0(4-Pyrimidinecarboxylic acid, 5-amino-2-(methylsulfonyl)-, ethyl ester)
• 1263216-10-9(2-methanesulfonyl-6-methylpyrimidine-4-carboxylic acid)
• 1554422-53-5(methyl 5-amino-2-(methylsulfanyl)pyrimidine-4-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)